Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Centre, 929 Higashi-cho, Kamogawa-shi, Chiba, 296-8602, Japan.
Division of Rheumatology, Department of Internal Medicine, Kameda Medical Centre.
Int J Infect Dis. 2022 Apr;117:322-325. doi: 10.1016/j.ijid.2022.02.031. Epub 2022 Feb 18.
We report a case of a Japanese man with severe rhabdomyolysis and multiple thrombosis of arterioles after the first dose of mRNA-1273 vaccine. He developed rapidly progressive rhabdomyolysis and infarctions of multiple organs. Antiplatelet factor 4 antibody test was negative. Despite the intensive supportive care, including aggressive fluid administration, hemodialysis, administration of anticoagulants, high-dose steroid, and eculizumab, the patient ultimately died of multiple organ failure. Autopsy revealed multiple thrombosis in the arterioles and organ necrosis. Low serum complements and C3 deposition in the renal glomeruli detected by immunofluorescence suggested a possible immune-mediated mechanism. To our knowledge, this is the first case report of rhabdomyolysis and multiple thrombosis of the arterioles as an adverse event following COVID-19 vaccination.
我们报告了一例日本男性在接种 mRNA-1273 疫苗第一针后出现严重横纹肌溶解症和多发性小动脉血栓形成。他迅速发展为横纹肌溶解症和多个器官梗死。抗血小板因子 4 抗体检测为阴性。尽管进行了包括积极补液、血液透析、抗凝治疗、大剂量类固醇和依库珠单抗在内的强化支持治疗,但患者最终死于多器官衰竭。尸检显示小动脉多处血栓形成和器官坏死。免疫荧光检查发现血清补体水平降低,C3 在肾小球沉积,提示可能存在免疫介导的机制。据我们所知,这是首例 COVID-19 疫苗接种后出现横纹肌溶解症和多发性小动脉血栓形成的不良事件报告。